Get started

Europe

EURUSD Channelling Lower Towards 1.17Trend Analysis The main view of this trade idea is on the 2-Hour chart. The Forex Cross EURUSD is in a rather choppy downward trend channel, making lower highs and lower lows, after hitting resistance around the 1.195 price level. At the time of publishing, EURUSD is trading at the middle of the channel. Technical Indicators EURUSD is currently below its short (25-SMA), medium (75-SMA) and fractal moving averages, an indication that it is in a bearish trend. Also the KST recently had a negative crossover, further confirmation of the bearish move. The RSI is trading below 50. Recommendation The recommendation will be to go short at market. EURUSD is expected to decline towards 1.17, 0.56% away from current levels. Stop loss on this position is set around the 1.184 level, above the resistance trend line of the downward trend channel. Disclaimer The views expressed are mine and do not represent the views of my employers and business partners. Persons acting on these recommendations are doing so at their own risk. These recommendations are not a solicitation to buy or to sell but are for purely discussion purposes. At the time publishing, I have a position in EURUSD.
Short
by Ceddy86
IBEX 35 about to be super bullishMonthly timeframe draws a macro descending resistance going back to 2007. This line has meant a significant bounce each time price touched it. This time the resistance is coliving with monthly ema 200 which brings me to expect another bounce although this time it might not be significant. Price is moving upwards inside an ascending paralel channel for few weeks now and the TVC:IBEX35 has been showing strength when touching the downside. On a daily basis, a bounce at 8.950-9.000 down to weekly ema 200 and the downside of the channel at 8.750 on a quick visit to this level would be the natural price retracement enough to take air, reload, and then finally trespass the 9.000 level among with the ema9 and 200 cross on the weekly. An alternative would be to succeed at first attempt and then retest 9.000 as support, I do see this level as a significant barrier so I expect the price to retest it either way. Let's see if the market is ready enough move to continue upwards! PS: This is general market information for educational and entertainment purposes only, and does not constitute investment advice.
TVC:IBEX35Long
by agt_cat
EUR - FUNDAMENTAL DRIVERS1. Virus Situation. The outlook for EUR remains tied to the EU's ability to overcome its coronavirus pandemic. At present, the outlook appears bleak, with many European countries entering third waves and reinstating or prolonging economically damaging lockdown restrictions. Vaccinations remain frustratingly slow, a result of ongoing supply constraints and rising anti-vaccine attitudes. 2. The Monetary Policy outlook for the ECB. Even though the FED and BOE are nowhere close to hawkish, they are far less dovish than the ECB, who has decided to front-load asset purchases to keep EU bond yields from rising too fast. The string of contradicting comments also shows a possible growing rift among the GC which could prove problematic when it comes to potentially altering policy in the months ahead. Even though price action has been very supportive for the EUR in the past two weeks, we think majority of that was due to positioning unwinding in cross pairs (EURGBP) as well as the EUR’s sensitive to moves in the US Dollar which has been pushing lower for the past few weeks. The fundamental bearish bias remains intact. 3. The country’s economic developments. The vaccination roll out and additional lockdowns has weighed on EU growth prospects, with growth differentials for the EU versus the US and UK widening. Fiscal support is another factor where the EU Recovery Fund is yet to be ratified while the US and UK have both rolled out additional stimulus and plans more in the months ahead (US). For the EUR’s growth and fundamental outlook to improve, it will need to overcome its ongoing vaccination frustrations and see a significant increase in the total number of citizens vaccinated.
by thunderpips
EUR - FUNDAMENTAL DRIVERS1. Virus Situation The outlook for EUR remains tied to the EU's ability to overcome its coronavirus pandemic. At present, the outlook appears bleak, with many European countries entering third waves and reinstating or prolonging economically damaging lockdown restrictions. Vaccinations remain frustratingly slow, a result of ongoing supply constraints and rising anti-vaccine attitudes. 2. The Monetary Policy outlook for the ECB Even though the FED and BOE are nowhere close to hawkish, they are far less dovish than the ECB, who has decided to front-load asset purchases to keep EU bond yields from rising too fast. The string of contradicting comments also shows a possible growing rift among the GC which could prove problematic when it comes to potentially altering policy in the months ahead. 3. The country’s economic developments The vaccination roll out and additional lockdowns has weighed on EU growth prospects, with growth differentials for the EU versus the US and UK widening. Fiscal support is another factor where the EU Recovery Fund is yet to be ratified while the US and UK have both rolled out additional stimulus and plans more in the months ahead (US). For the EUR’s growth and fundamental outlook to improve, it will need to overcome its ongoing vaccination frustrations and see a significant increase in the total number of citizens vaccinated.
by thunderpips
ALNOV NOVACYT Novacyt big fall today, don't worry medium long term still hasn't broken level but keep an eye out for volatility next week we recommend that you buy if you can to the level you think is appropriate, it is a company that in the medium term has high expectations L.E.D Capital Management has investments and has had large investments in ALNOV, continuing to rely on its potential - THIS IS NOT A FINANCIAL ADVICE AT ALL- Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide. HE'S GOT BIG CONTRACTS FOR COVID TESTING. A cordial greeting good investment. In Spain at 9/04/2021 carefully L.E.D
EURONEXT:ALNOVLong
by wallstreetstocks